I guess they have confirmed multiple patients dosed so that is good. No problems like Ibx where they couldn't get volunteers. seems quite surprising that they give no indication of efficacy. Seems to indicate it will be a fair wait until data is released. No adverse reaction is good start for phase 1 part.
RCE Price at posting:
91.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)